LENSAR (NASDAQ:LNSR) vs. United American Healthcare (OTCMKTS:UAHC) Head to Head Contrast

LENSAR (NASDAQ:LNSR) and United American Healthcare (OTCMKTS:UAHC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for LENSAR and United American Healthcare, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1	0	2	0	2.33
United American Healthcare	0	0	0	0	0.00

LENSAR presently has a consensus price target of $11.50, suggesting a potential upside of 32.49%. Given LENSAR’s stronger consensus rating and higher possible upside, analysts plainly believe LENSAR is more favorable than United American Healthcare.

Profitability

This table compares LENSAR and United American Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LENSAR	57.57%	-529.08%	50.03%
United American Healthcare	N/A	N/A	N/A

Earnings & Valuation

This table compares LENSAR and United American Healthcare”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44 million	1.83	-$34.28 million	($0.33)	-26.30
United American Healthcare	N/A	N/A	$240,000.00	N/A	N/A

United American Healthcare has lower revenue, but higher earnings than LENSAR.

Insider & Institutional Ownership

40.1% of LENSAR shares are held by institutional investors. 65.8% of LENSAR shares are held by insiders. Comparatively, 14.3% of United American Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

LENSAR has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.64, suggesting that its share price is 264% less volatile than the S&P 500.

Summary

LENSAR beats United American Healthcare on 9 of the 11 factors compared between the two stocks.

About LENSAR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.